Literature DB >> 22575901

Intraocular pressure elevation is a delayed-onset complication after successful vitrectomy for stages 4 and 5 retinopathy of prematurity.

Chiharu Iwahashi-Shima1, Atsuya Miki, Toshimitsu Hamasaki, Yasumasa Otori, Kenji Matsushita, Yoshiaki Kiuchi, Morio Okada, Shunji Kusaka.   

Abstract

PURPOSE: To determine the incidence and risk factors for delayed-onset intraocular pressure (IOP) elevations after vitrectomy for Stages 4 and 5 retinopathy of prematurity and, in addition, to determine the results of treating the IOP elevations.
METHODS: Fifty-five consecutive eyes with successful retinal reattachment and at least 24 months of follow-up after vitrectomy were studied. The ophthalmic examinations included slit-lamp biomicroscopy, wide-field digital retinal imaging, and IOP measurements. Eyes were classified into 2 groups: eyes with a postoperative IOP elevation to ≥ 21 mmHg and eyes whose IOP was always <21 mmHg.
RESULTS: Eight eyes (14.5%) developed an IOP elevation to ≥ 21 mmHg from 2 months to 4 months (median: 2.5 months) after the vitrectomy. In two of these eyes, the IOP was controlled with antiglaucoma medications. In the other six eyes, trabeculotomy for eyes with open angles and trabeculectomy or goniosynechialysis for eyes with closed angles were performed. The IOPs were successfully controlled after an average of 1.5 glaucoma surgeries. Multivariate logistic regression analyses identified that a young gestational age (odds ratio = 1.147, 95% confidence interval: 1.024-1.346) and lensectomy (odds ratio = 8.795, 95% confidence interval: 1.262-183.3) were significantly associated with the IOP elevation.
CONCLUSION: Delayed-onset IOP elevation after vitrectomy for retinopathy of prematurity occurs in 14.5% of the eyes, and it is significantly associated with a young gestational age and presence of lensectomy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22575901     DOI: 10.1097/IAE.0b013e3182551c54

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  4 in total

1.  Safety and efficacy of simultaneous bilateral 25-gauge lens-sparing vitrectomy for vascularly active stage 4 retinopathy of prematurity.

Authors:  P K Shah; V Narendran; N Kalpana
Journal:  Eye (Lond)       Date:  2015-05-22       Impact factor: 3.775

2.  Treatment for stage 4A retinopathy of prematurity: laser and/or ranibizumab.

Authors:  Emine Alyamaç Sukgen; Yusuf Koçluk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-06       Impact factor: 3.117

3.  Short-term incidence and management of glaucoma after successful surgery for stage 4 retinopathy of prematurity.

Authors:  Parijat Chandra; Ruchir Tewari; Nitesh Salunkhe; Devesh Kumawat; Abadh K Chaurasia; Viney Gupta
Journal:  Indian J Ophthalmol       Date:  2019-06       Impact factor: 1.848

4.  Hybrid 23/27 Gauge Vitrectomy - Combining the Charm of 27G with the Efficacy of 23G.

Authors:  Justus G Garweg; Dean Ouassi; Isabel B Pfister
Journal:  Clin Ophthalmol       Date:  2020-01-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.